Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve This is to inform you ....
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Ltd has informed exchanges that a Board meeting is scheduled for May 18, 2026. The meeting will consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. Additionally, the Board will consider and recommend final dividend for FY2026. The trading window for designated persons has been closed from April 1, 2026 and will reopen 48 hours after the financial results are declared. This is a standard regulatory intimation filed in advance of quarterly/annual results announcement.
This is a routine pre-results announcement notice. The actual financial performance and dividend details will be disclosed after the Board meeting on May 18, 2026. Shareholders should await the official results announcement for any material decisions.